Journal of Clinical and Translational Science (Oct 2020)

Lung cancer screening in Appalachian Kentucky: The impact of Lung-RADS on subsequent testing and cancer identification

  • Roberto Cardarelli,
  • Vashisht Madabhushi,
  • Kacie Bledsoe,
  • Anthony Weaver

DOI
https://doi.org/10.1017/cts.2019.416
Journal volume & issue
Vol. 4
pp. 468 – 471

Abstract

Read online

The National Lung Cancer Screening Trial (NLST) demonstrated the use of low dose helical computed tomography (LDCT) scans for lung cancer screening. However, the NLST was implemented in urban hospitals and prior to the Lung CT Screening Reporting and Data System (Lung-RADS). In this retrospective cohort study, 774 eligible patients received LDCT screening using Lung-RADS criteria. Eighty-four patients (10.9%) had subsequent testing performed compared to 24.2% in the NLST study. Of those with subsequent testing, 21.4% were diagnosed with lung cancer compared to only 4.6% in the NLST study. Lung-RADS significantly reduced unnecessary testing while identifying higher rates of lung cancer compared to the NLST.

Keywords